Trial Information: 45 young patients will be recruited for a Phase I study of the new telemerase inhibitor imetelstat. Patients must be under 21 years old and have any solid tumor or lymphoma cancer, except for brain tumors or metastases. They must have relapsed or been resistant (refractory) to previous retreatment.
Showing posts with label Imetelstat. Show all posts
Showing posts with label Imetelstat. Show all posts
Friday, January 14, 2011
Subscribe to:
Posts (Atom)